FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Hogarty

Research Profile

Disorders

Living Beings

Genes & Molecular Sequences

Physiology

Chemicals & Drugs

Anatomy

Concepts & Ideas

Risk Factors

Procedures

Gene Expression Profiling

Co-author Network

Publications

TOP 3
Julie R Park; Rochelle Bagatell; Susan L Cohn; Michael D Hogarty; Wendy B London; John M Maris; Katherine M Mattay
Children's Oncology Group's 2013 blueprint for research: Neuroblastoma.
Rie Suganuma; Larry L Wang; Gabriele Amann; Klaus Beiske; Susan Cohn; Catherine J Cullinane; Emanuele S G d'Amore; Claudio Gambini; Julie M Gastier-Foster; Michael D Hogarty; JA Jarzembowski; Vijay V Joshi; Wendy B London; A Thomas Look; John M Maris; Arlene Naranjo; Samuel Navarro; Julie R Park; Michel Peuchmaur; Hideki Sano; Robert C Seeger; Hiroyuki Shimada
Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee.
Guoliang Qing; Michael D Hogarty; Bo Li; Xueyuan Liu; John M Maris; Patrick A Mayes; Nicolas Skuli; Craig B Thompson; Annette Vu; Zandra E Walton; David R Wise; M Celeste Simon
ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Hogarty (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Julie R Park; Rochelle Bagatell; Susan L Cohn; Michael D Hogarty; Wendy B London; John M Maris; Katherine M Mattay
Children's Oncology Group's 2013 blueprint for research: Neuroblastoma.
Pediatric blood & cancer 2013;60(6):985-93.
2013: Rie Suganuma; Larry L Wang; Gabriele Amann; Klaus Beiske; Susan Cohn; Catherine J Cullinane; Emanuele S G d'Amore; Claudio Gambini; Julie M Gastier-Foster; Michael D Hogarty; JA Jarzembowski; Vijay V Joshi; Wendy B London; A Thomas Look; John M Maris; Arlene Naranjo; Samuel Navarro; Julie R Park; Michel Peuchmaur; Hideki Sano; Robert C Seeger; Hiroyuki Shimada
Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee.
Pediatric blood & cancer 2013;60(3):363-70.
2012: Guoliang Qing; Michael D Hogarty; Bo Li; Xueyuan Liu; John M Maris; Patrick A Mayes; Nicolas Skuli; Craig B Thompson; Annette Vu; Zandra E Walton; David R Wise; M Celeste Simon
ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation.
Cancer cell 2012;22(5):631-44.
2012: Kelly C Goldsmith; Michelle Gross; Rong Guo; Xueyuan Liu; Dema Luyindula; Susan Peirce; C Patrick Reynolds; Michael Sliozberg; Annette Vu; Huaqing Zhao; Michael D Hogarty
Mitochondrial Bcl-2 family dynamics define therapy response and resistance in neuroblastoma.
Cancer research 2012;72(10):2565-77.
2012: Michael D Hogarty; John M Maris
PI3King on MYCN to improve neuroblastoma therapeutics.
Cancer cell 2012;21(2):145-7.
2012: Steven G Dubois; Ethan Geier; Kathleen Giacomini; Michael D Hogarty; Susan Kreissman; Wendy B London; John M Maris; Daniel Martinez; Arlene Naranjo; John Neuhaus; Bruce Pawel; Mark Segal; Gregory Yanik; Sook Wah Yee; Edward Attiyeh; David Baker; Vandana Batra; Katherine K Matthay
Evaluation of Norepinephrine Transporter Expression and Metaiodobenzylguanidine Avidity in Neuroblastoma: A Report from the Children's Oncology Group.
International journal of molecular imaging 2012;2012():250834.
2011: Katleen De Preter; Elzbieta Drozynska; Angelika Eggert; Michael D Hogarty; Ewa Izycka-Swieszewska; Geneviève Laureys; Wendy B London; Pieter Mestdagh; Jan J Molenaar; Arlene Naranjo; Rosa Noguera; Marta Piqueras; Benjamin Schowe; Alexander Schramm; Johannes H Schulte; Frank Speleman; Raymond L Stallings; Nadine Van Roy; Peter van Sluis; Isabella Bray; Kenneth Bryan; Victoria Castel; Caifu Chen; Joëlle Vermeulen; Rogier Versteeg; Fjoralba Zeka; Jo Vandesompele
miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(24):7684-92.
2011: Grant T Liu; Nicholas R Mahoney; Robert A Avery; Michael D Hogarty; Sheryl J Menacker; Martin C Wilson; John M Maris
Pediatric horner syndrome.
Archives of ophthalmology 2011;129(8):1108-9; author reply 1109.
2011: Michael D Hogarty
IL-17A in LCH: systemic biomarker, local factor, or none of the above?
Molecular therapy : the journal of the American Society of Gene Therapy 2011;19(8):1405-6.
2010: Carol L Shields; Michael D Hogarty; Brad E Kligman; Colleen Christian; Hormoz Ehya; Jerry A Shields
Langerhans cell histiocytosis of the uvea with neovascular glaucoma: diagnosis by fine-needle aspiration biopsy and management with intraocular bevacizumab and brachytherapy.
Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus / American Association for Pediatric Ophthalmology and Strabismus 2010;14(6):534-7.
2010: K C Goldsmith; B J Lestini; M Gross; L Ip; A Bhumbla; X Zhang; H Zhao; X Liu; Michael D Hogarty
BH3 response profiles from neuroblastoma mitochondria predict activity of small molecule Bcl-2 family antagonists.
Cell death and differentiation 2010;17(5):872-82.
2010: Michael D Hogarty
Mcl1 becomes ubiquitin-ous: new opportunities to antagonize a pro-survival protein.
Cell research 2010;20(4):391-3.
2009: Nicholas F Evageliou; Michael D Hogarty
Disrupting polyamine homeostasis as a therapeutic strategy for neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(19):5956-61.
2009: Chizuko Okamatsu; Wendy B London; Arlene Naranjo; Michael D Hogarty; Julie M Gastier-Foster; A Thomas Look; Michael P LaQuaglia; John M Maris; Susan Cohn; Katherine K Matthay; Robert C Seeger; Tsutomu Saji; Hiroyuki Shimada
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.
Pediatric blood & cancer 2009;53(4):563-9.
2009: Valerie Combaret; Michael D Hogarty; Wendy B London; Patrick McGrady; Isabelle Iacono; Stephanie Brejon; Katrien Swerts; Rosa Noguera; Nicole Gross; Raphael Rousseau; Alain Puisieux
Influence of neuroblastoma stage on serum-based detection of MYCN amplification.
Pediatric blood & cancer 2009;53(3):329-31.
2009: Brian J Lestini; Kelly C Goldsmith; Mark N Fluchel; Xueyuan Liu; Niel L Chen; Bella Goyal; Bruce R Pawel; Michael D Hogarty
Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists.
Cancer biology & therapy 2009;8(16):1587-95.
2009: Joëlle Vermeulen; Katleen De Preter; Arlene Naranjo; Liesbeth Vercruysse; Nadine Van Roy; Jan Hellemans; Katrien Swerts; Sophie Bravo; Paola Scaruffi; Gian Paolo Tonini; Bruno De Bernardi; Rosa Noguera; Marta Piqueras; Adela Cañete; Victoria Castel; Isabelle Janoueix-Lerosey; Olivier Delattre; Gudrun Schleiermacher; Jean Michon; Valérie Combaret; Matthias Fischer; André Oberthuer; Peter F Ambros; Klaus Beiske; Jean Bénard; Bárbara Marques; Hervé Rubie; Janice Kohler; Ulrike Pötschger; Ruth Ladenstein; Michael D Hogarty; Patrick McGrady; Wendy B London; Geneviève Laureys; Frank Speleman; Jo Vandesompele
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study.
The lancet oncology 2009;10(7):663-71.
2009: Kelly C Goldsmith; Michael D Hogarty
Small-molecule BH3 mimetics to antagonize Bcl-2-homolog survival functions in cancer.
Current opinion in investigational drugs (London, England : 2000) 2009;10(6):559-71.
2009: Olesya Chayka; Daisy Corvetta; Michael Dews; Alessandro E Caccamo; Izabela Piotrowska; Giorgia Santilli; Sian Gibson; Neil J Sebire; Nourredine Himoudi; Michael D Hogarty; John Anderson; Saverio Bettuzzi; Andrei Thomas-Tikhonenko; Arturo Sala
Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas.
Journal of the National Cancer Institute 2009;101(9):663-77.
2008: Michael D Hogarty; Murray D Norris; Kimberly Davis; Xueyuan Liu; Nicholas F Evageliou; Candace S Hayes; Bruce Pawel; Rong Guo; Huaqing Zhao; Eric Sekyere; Joanna Keating; Wayne Thomas; Ngan Ching Cheng; Jayne Murray; Janice Smith; Rosemary Sutton; Nicola Venn; W London; Allen Buxton; Susan K Gilmour; Glenn M Marshall; Michelle Haber
ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma.
Cancer research 2008;68(23):9735-45.
2008: Kiersten J Kugeler; Paul S Mead; Karin L McGowan; Jon M Burnham; Michael D Hogarty; Eduardo Ruchelli; Kerry Pollard; Brigitte Husband; Caryn Conley; Tanya Rivera; THEODOROS KELESIDIS; Walter M Lee; Walburga Mabey; Jonas M Winchell; Heather L Stang; J Erin Staples; Linda J Chalcraft; Jeannine M Petersen
Isolation and characterization of a novel Francisella sp. from human cerebrospinal fluid and blood.
Journal of clinical microbiology 2008;46(7):2428-31.
2008: X Liu; P Mazanek; V Dam; Q Wang; H Zhao; R Guo; J Jagannathan; Avital Cnaan; John M Maris; Michael D Hogarty
Deregulated Wnt/beta-catenin program in high-risk neuroblastomas without MYCN amplification.
Oncogene 2008;27(10):1478-88.
2007: John M Maris; Michael D Hogarty; Rochelle Bagatell; Susan Cohn
Neuroblastoma.
Lancet 2007;369(9579):2106-20.
2007: Susan R Rheingold; Michael D Hogarty; Susan M Blaney; James A Zwiebel; Calies Sauk-Schubert; Reddy Chandula; Mark Krailo; Peter Charles Adamson
Phase I Trial of G3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: a Children's Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(12):1512-8.
2006: Christina M Coughlin; Mark D Fleming; Richard G Carroll; Bruce R Pawel; Michael D Hogarty; Xiaochuan Shan; Barbara A Vance; Jarish N Cohen; Sonya Jairaj; Elaina M Lord; Michael H Wexler; Gwenn-Aël H Danet-Desnoyers; Jack L Pinkus; Geraldine S Pinkus; John M Maris; Stephan A Grupp; Robert H Vonderheide
Immunosurveillance and survivin-specific T-cell immunity in children with high-risk neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(36):5725-34.
2006: Nicholas R Mahoney; Grant T Liu; Sheryl J Menacker; Martin C Wilson; Michael D Hogarty; John M Maris
Pediatric horner syndrome: etiologies and roles of imaging and urine studies to detect neuroblastoma and other responsible mass lesions.
American journal of ophthalmology 2006;142(4):651-9.
2006: Kelly C Goldsmith; X Liu; V Dam; B T Morgan; Mayadah Shabbout; Avital Cnaan; Anthony Letai; S J Korsmeyer; Michael D Hogarty
BH3 peptidomimetics potently activate apoptosis and demonstrate single agent efficacy in neuroblastoma.
Oncogene 2006;25(33):4525-33.
2006: Nektarios I Lountzis; Michael D Hogarty; Ho J Kim; JACQUELINE JUNKINS-HOPKINS
Cutaneous metastatic chordoma with concomitant tuberous sclerosis.
Journal of the American Academy of Dermatology 2006;55(2 Suppl):S6-10.
2006: Vincent Dam; Brian T Morgan; Pavel Mazanek; Michael D Hogarty
Mutations in PIK3CA are infrequent in neuroblastoma.
BMC cancer 2006;6():177.
2005: Kelly C Goldsmith; Michael D Hogarty
Targeting programmed cell death pathways with experimental therapeutics: opportunities in high-risk neuroblastoma.
Cancer letters 2005;228(1-2):133-41.
2005: Peter White; Patricia M Thompson; Takahiro Gotoh; Erin R Okawa; Jun Igarashi; Marleen Kok; Cynthia Winter; Simon G Gregory; Michael D Hogarty; John M Maris; Garrett M Brodeur
Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma.
Oncogene 2005;24(16):2684-94.
2003: Tatsuro Tajiri; Xueyuan Liu; Patricia M Thompson; Shinji Tanaka; Sachiyo Suita; Huaqing Zhao; John M Maris; George C Prendergast; Michael D Hogarty
Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(9):3345-55.
2003: Michael D Hogarty
The requirement for evasion of programmed cell death in neuroblastomas with MYCN amplification.
Cancer letters 2003;197(1-2):173-9.
2003: Qun Wang; George Hii; Susanne Shusterman; Yael Mosse; Cynthia L Winter; Chun Guo; Huaqing Zhao; Eric F Rappaport; Michael D Hogarty; John M Maris
ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.
Cancer research 2003;63(7):1631-5.
2002: John M Maris; Mitchell J Weiss; Yael Mosse; George Hii; Chun Guo; Peter White; Michael D Hogarty; Tamar Mirensky; Garrett M Brodeur; Timothy R Rebbeck; Margrit Urbanek; Susanne Shusterman
Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13.
Cancer research 2002;62(22):6651-8.
2002: Michael D Hogarty; Cynthia L Winter; Xueyuan Liu; Chun Guo; Peter White; A Thomas Look; Garrett M Brodeur; John M Maris
No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3.
Cancer research 2002;62(22):6481-4.
2001: Michael A Grotzer; Michael D Hogarty; Anna Janss; X Liu; Huaqing Zhao; Angelika Eggert; Leslie N Sutton; Lucy B Rorke; Garrett M Brodeur; Peter C Phillips
MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2425-33.
2001: P M Thompson; John M Maris; Michael D Hogarty; Robert C Seeger; Charles Patrick Reynolds; Garrett M Brodeur; Peter White
Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.
Cancer research 2001;61(2):679-86.
2001: Michael D Hogarty; John M Maris; Peter White; Chun Guo; Garrett M Brodeur
Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
Medical and pediatric oncology 2001;36(1):52-5.
2001: Peter White; Patricia M Thompson; BA Seifried; Erik P Sulman; SJ Jensen; Chun Guo; John M Maris; Michael D Hogarty; C Allen; Jaclyn A Biegel; Tara C Matise; Simon G Gregory; Charles Patrick Reynolds; Garrett M Brodeur
Detailed molecular analysis of 1p36 in neuroblastoma.
Medical and pediatric oncology 2001;36(1):37-41.
2001: John M Maris; Chun Guo; D Blake; Peter White; Michael D Hogarty; Patricia M Thompson; V Rajalingam; Robert B Gerbing; DO Stram; KK Matthay; Robert C Seeger; Garrett M Brodeur
Comprehensive analysis of chromosome 1p deletions in neuroblastoma.
Medical and pediatric oncology 2001;36(1):32-6.
2001: John M Maris; Chun Guo; Peter White; Michael D Hogarty; Patricia M Thompson; DO Stram; Robert B Gerbing; KK Matthay; Robert C Seeger; Garrett M Brodeur
Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma.
Medical and pediatric oncology 2001;36(1):24-7.
2000: Michael D Hogarty; X Liu; Patricia M Thompson; Peter White; Erik P Sulman; John M Maris; Garrett M Brodeur
BIN1 inhibits colony formation and induces apoptosis in neuroblastoma cell lines with MYCN amplification.
Medical and pediatric oncology 2000;35(6):559-62.
2000: Chun Guo; Peter White; Michael D Hogarty; Garrett M Brodeur; Robert B Gerbing; Daniel O Stram; John M Maris
Deletion of 11q23 is a frequent event in the evolution of MYCN single-copy high-risk neuroblastomas.
Medical and pediatric oncology 2000;35(6):544-6.
2000: Mitchell J Weiss; Chun Guo; Susanne Shusterman; George Hii; T L Mirensky; Peter White; Michael D Hogarty; Timothy R Rebbeck; D Teare; M Urbanek; Garrett M Brodeur; John M Maris
Localization of a hereditary neuroblastoma predisposition gene to 16p12-p13.
Medical and pediatric oncology 2000;35(6):526-30.
2000: Michael D Hogarty; X Liu; Chun Guo; Patricia M Thompson; Mitchell J Weiss; Peter White; Erik P Sulman; Garrett M Brodeur; John M Maris
Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas.
Medical and pediatric oncology 2000;35(6):512-5.
2000: John M Maris; Mitchell J Weiss; Chun Guo; Robert B Gerbing; Daniel O Stram; Peter White; Michael D Hogarty; Erik P Sulman; Patricia M Thompson; John N Lukens; Katherine K Matthay; Robert C Seeger; Garrett M Brodeur
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(9):1888-99.
2000: Alexa N Hogarty; AM Leahey; Huaqing Zhao; Michael D Hogarty; Nancy Bunin; Avital Cnaan; Stephen M Paridon
Longitudinal evaluation of cardiopulmonary performance during exercise after bone marrow transplantation in children.
The Journal of pediatrics 2000;136(3):311-7.
1999: Chun Guo; Peter White; Mitchell J Weiss; Michael D Hogarty; Patricia M Thompson; DO Stram; Robert B Gerbing; KK Matthay; Robert C Seeger; Garrett M Brodeur; John M Maris
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas.
Oncogene 1999;18(35):4948-57.
1998: Michael D Hogarty; Peter White; Erik P Sulman; Garrett M Brodeur
Mononucleotide repeat instability is infrequent in neuroblastoma.
Cancer genetics and cytogenetics 1998;106(2):140-3.
1997: Garrett M Brodeur; John M Maris; DJ Yamashiro; Michael D Hogarty; Peter White
Biology and genetics of human neuroblastomas.
Journal of pediatric hematology/oncology 1997;19(2):93-101.